Indian - Danish Life Sciences Merger: Nordic Contract Research Goes GlobalBy Ecron Acunova, PRNE
Tuesday, May 17, 2011
BANGALORE, India and COPENHAGEN, Denmark, May 18, 2011 - Ecron Acunova, a full-service international CRO, today announced the
merger with Danish aCROnordic, specialized in Nordic clinical research. Ecron
Acunova thereby extends its global activities and aCROnordic - now Ecron
Acunova A/S - goes global.
Ecron Acunova A/S is based in bio-science park, SCION DTU near
Copenhagen. Mr. Søren Strøh, Founder of aCROnordic, continues his role as
CEO, and Pharma Executive and biotech pioneer Ingelise Saunders has been
elected Chairman of the Board of Ecron Acunova A/S.
Mr. Prasanna, Chairman and Founder of Ecron Acunova said: "Several
examples of innovation in GE medical and Wipro have inspired me to apply
similar principles to accelerate speed to market in clinical research. In
clinical trials a basic factor is fast enrolment of patients. Through an
intelligent combination of countries and competencies, we can speed new drugs
to market at a modest cost."
Invest in Denmark has helped Ecron Acunova establish in Denmark and
appreciates the increasing Asian interest. Director of Invest in Denmark, Ole
Frijs-Madsen, explains:"Denmark has unique life sciences competences,
especially within research and development, and we further strengthen this
business area by welcoming a global player like Ecron Acunova."
CEO Søren Strøh stated: "aCROnordic goes global as the first Danish CRO.
We may offer international clinical services and a flexible cost effective
high quality approach leveraging resources in Asia and Europe without
potential cultural barriers. We expect to attract international clinical
trial projects offering access to Nordic sites and highly qualified clinical
research experience and skills."
Ecron Acunova is an expert CRO, offering full-service clinical research,
including clinical operations, data management, biostatistics,
pharmacovigilance, PK/PD services and central lab to pharma, biotech, medical
device, nutrition and diagnostic companies. Ecron Acunova covers 19 Western &
Eastern European countries as well as nine South Asian & South East Asian
countries. Ecron Acunova operates each region as a priority market with
European HQ in Frankfurt, Asian HQ in Bangalore, and US HQ at Princeton. With
a team of 385 professionals including 73 MDs and PhDs Ecron Acunova is
reputed to accelerate pharma time-to-market cost effectively.
Media contacts D A Prasanna Tel: +91-80-66-91-57-00 email@example.com Mobius, SJR i-park, EPIP, Whitefield Bangalore 560066 India Søren Strøh Tel: +45-45-16-88-00 firstname.lastname@example.org Scion DTU, Kogle Allé 5 2970 Hørsholm Denmark
Tags: Bangalore, denmark, Ecron Acunova, India, India And Copenhagen, May 18